1. Home
  2. COCO vs NNNN Comparison

COCO vs NNNN Comparison

Compare COCO & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

HOLD

Current Price

$54.60

Market Cap

2.5B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$37.00

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCO
NNNN
Founded
2004
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
1.0B
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
COCO
NNNN
Price
$54.60
$37.00
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$55.13
N/A
AVG Volume (30 Days)
923.0K
25.7K
Earning Date
10-29-2025
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
15.16
N/A
EPS
1.15
0.06
Revenue
$609,286,000.00
$8,185,146.00
Revenue This Year
$18.22
N/A
Revenue Next Year
$13.69
N/A
P/E Ratio
$47.36
$684.40
Revenue Growth
23.12
21.95
52 Week Low
$25.79
$5.18
52 Week High
$55.09
$55.65

Technical Indicators

Market Signals
Indicator
COCO
NNNN
Relative Strength Index (RSI) 74.25 67.42
Support Level $53.63 $21.13
Resistance Level $55.09 $29.38
Average True Range (ATR) 2.08 4.90
MACD 0.47 2.01
Stochastic Oscillator 93.61 75.29

Price Performance

Historical Comparison
COCO
NNNN

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: